Sharps Compliance Has Collected and Treated More Than 3.2 Million Pounds of Unused, Ultimate-User Medications
Sharps Compliance is committed to helping communities and citizens dispose of unused medications to combat the growing epidemic of prescription drug abuse and accidental poisonings throughout the year. The company has been a longtime supporter of the DEA drug take back event, which occurs annually in April and October.
Additionally, Sharps Compliance announces that it will attend the Rx Drug Abuse & Heroin Summit, the largest annual conference addressing the opioid crisis. This conference, which focuses on treatment and prevention, will take place in Atlanta, GA on
According to the
Prevention and education are key components for fighting the opioid crisis. JAMA Surgery reported that as many as 92% of patients don’t finish their painkillers, and fewer than 10% safely dispose of the leftover pills. A recent study by Purdue Pharma found that patients who received education about the importance of safe disposal were approximately three times more likely to dispose of their unused medications.
“As a leader in the industry, we believe that convenient and proper disposal of prescription medication is a very important element in reducing prescription drug abuse, particularly when combined with education, research, and treatment,” said David P. Tusa, President and Chief Executive Officer of
Sharps Compliance has placed approximately 3,000 MedSafe collection receptacles in retail and hospital pharmacies and long-term care, drug treatment, and law enforcement facilities since the release of the updated DEA disposal regulations in 2014. To date, customers have returned over 28,000 inner liners with over 1.2 million pounds of unused medications. Sharps has sold nearly 3.6 million TakeAway Medication Recovery Envelopes since 2009.
MedSafe is an ultimate-user unused medication collection and disposal system, which accepts controlled (Schedules II-V) and non-controlled medicines. It combines industry-leading secure receptacles with the reverse distribution, destruction, and reporting capabilities of Sharps Compliance via our patented inner liner system. The patent-pending MedSafe medication disposal program operates under and is fully-compliant with the
The TakeAway Envelopes are available at participating pharmacies and on the Company’s website. Customers can simply purchase a USPS postage-paid TakeAway Envelope, place their unused medications in the envelope, and drop it in any mailbox. The TakeAway Envelope is specially designed for the proper disposal, transportation, and treatment of all drugs, including controlled substances. Local and federal governments, as well as the private sector, have stepped up to provide the envelopes to communities and citizens to help with medication disposal.
Sharps Compliance partners with public and private entities to address the growing problem of opioid abuse, working closely with federal agencies, such as the
Headquartered in Houston, Texas, Sharps Compliance is a leading full-service national provider of comprehensive waste management services, including medical, pharmaceutical, and hazardous. Its key markets include healthcare facilities, pharmaceutical manufacturers, home healthcare providers, assisted living/long-term care, surgery centers, retail pharmacies and clinics, and the professional market, which is comprised of physicians, dentists, and veterinary practices. Sharps also provides two simple solutions for safe and easy disposal of unused medications: MedSafe collection receptacles and TakeAway Medication Recovery System Envelopes.
More information on Sharps Compliance and its products can be found on its website at www.sharpsinc.com.
|For more information contact:|
|Diana P. Diaz
|Sharps Compliance Corp.||John Nesbett/Jennifer Belodeau|
|Vice President and Chief Financial Officer||IMS Investor Relations|
|Phone: (713) 660-3547||Phone: (203) 972-9200|
|Email: [email protected]||Email: [email protected]|
Photos accompanying this announcement are available at
Source: Sharps Compliance Corp.